Literature DB >> 22052587

A case series to describe the clinical characteristics of foot ulceration in patients with rheumatoid arthritis.

Heidi J Siddle1, Jill Firth, Robin Waxman, E Andrea Nelson, Philip S Helliwell.   

Abstract

The aim of this study was to describe the clinical characteristics of foot ulceration in patients with rheumatoid arthritis (RA). Adults with RA and current foot ulceration but without diabetes were recruited. Clinical examination included assessment of RA disease activity, foot deformity, peripheral vascular disease, neuropathy and plantar pressures. Location, wound characteristics and time to healing were recorded for each ulcer. Participants completed the Health Assessment Questionnaire and Leeds Foot Impact Scale. Thirty-two cases with 52 current ulcers were recruited. Thirteen patients (41%) experienced more than one current ulcer: 5 (16%) had bilateral ulceration, 15 (47%) had previous ulceration at a current ulcer site. The majority (n = 33) of open ulcers were located over the dorsal aspect of the interphalangeal joints (n = 12), plantar aspect of the metatarsophalangeal joints (MTPJs) (n = 12) and medial aspect of first MTPJs (n = 9). In ulcerated limbs (n = 37), ankle brachial pressure index (ABPI) was <0.8 in 2 (5%); protective sensation was reduced in 25 (68%) and peak plantar pressures were >6 kg/cm(2) in 6 (16%). Mean ulcer size was 4.84 by 3.29 mm. Most ulcers (n = 42, 81%) were superficial; five (9.6%) were infected. Time to healing was available for 41 ulcers: mean duration was 28 weeks. Three ulcers remained open. In conclusion, foot ulceration in RA is recurrent and multiple ulcers are common. Whilst ulcers are small and shallow, time to achieve healing is slow, posing infection risk. Reduced protective sensation is common in affected patients. The prevalence of arterial disease is low but may be under estimated due to high intolerance of ABPI.

Entities:  

Mesh:

Year:  2011        PMID: 22052587     DOI: 10.1007/s10067-011-1886-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  Wound healing and TIME; new concepts and scientific applications.

Authors:  Gregory Schultz; David Mozingo; Marco Romanelli; Karl Claxton
Journal:  Wound Repair Regen       Date:  2005 Jul-Aug       Impact factor: 3.617

2.  The presence of forefoot problems and the role of surgery in patients with rheumatoid arthritis.

Authors:  G A Matricali; A Boonen; J Verduyckt; V Taelman; P Verschueren; A Sileghem; L Corluy; R Westhovens
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

Review 3.  Vasculitis and ulceration in rheumatic diseases of the foot.

Authors:  M I Cawley
Journal:  Baillieres Clin Rheumatol       Date:  1987-08

4.  Prospective assessment of the aorto-iliac segment by visual interpretation of frequency analysed Doppler waveforms--a comparison with arteriography.

Authors:  L Walton; T R Martin; M Collins
Journal:  Ultrasound Med Biol       Date:  1984 Jan-Feb       Impact factor: 2.998

5.  Development of a foot impact scale for rheumatoid arthritis.

Authors:  Philip Helliwell; Naomi Reay; Gill Gilworth; Anthony Redmond; Anita Slade; Alan Tennant; James Woodburn
Journal:  Arthritis Rheum       Date:  2005-06-15

6.  Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Authors:  W G Dixon; K Watson; M Lunt; K L Hyrich; A J Silman; D P M Symmons
Journal:  Arthritis Rheum       Date:  2006-08

7.  The foot: still the most important reason for walking incapacity in rheumatoid arthritis: distribution of symptomatic joints in 1,000 RA patients.

Authors:  Lollo Grondal; Birgitta Tengstrand; Birgitta Nordmark; Per Wretenberg; Andre Stark
Journal:  Acta Orthop       Date:  2008-04       Impact factor: 3.717

8.  The predictors of foot ulceration in patients with rheumatoid arthritis: a preliminary investigation.

Authors:  Jill Firth; Philip Helliwell; Claire Hale; Jackie Hill; E Andrea Nelson
Journal:  Clin Rheumatol       Date:  2008-06-10       Impact factor: 2.980

9.  Biomechanics of the foot in rheumatoid arthritis: identifying abnormal function and the factors associated with localised disease 'impact'.

Authors:  D E Turner; P S Helliwell; K Lohmann Siegel; J Woodburn
Journal:  Clin Biomech (Bristol, Avon)       Date:  2007-09-29       Impact factor: 2.063

10.  Methodological considerations for a randomised controlled trial of podiatry care in rheumatoid arthritis: lessons from an exploratory trial.

Authors:  Deborah E Turner; Philip S Helliwell; James Woodburn
Journal:  BMC Musculoskelet Disord       Date:  2007-11-06       Impact factor: 2.362

View more
  9 in total

Review 1.  Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.

Authors:  Eden Avishai; Kristina Yeghiazaryan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

2.  Clinical characteristics of foot ulceration in people with chronic gout.

Authors:  Keith Rome; Kathryn Erikson; Cynthia Otene; Hazra Sahid; Karyn Sangster; Peter Gow
Journal:  Int Wound J       Date:  2014-03-28       Impact factor: 3.315

Review 3.  Foot health in patients with rheumatoid arthritis-a scoping review.

Authors:  Minna Stolt; Riitta Suhonen; Helena Leino-Kilpi
Journal:  Rheumatol Int       Date:  2017-03-21       Impact factor: 2.631

4.  Risk factors for ulceration over tophi in patients with gout.

Authors:  Jianjun Xu; Cai Lin; Peng Zhang; Jianghui Ying
Journal:  Int Wound J       Date:  2016-10-10       Impact factor: 3.315

5.  Prevalence and microbiological characteristics of clinically infected foot-ulcers in patients with rheumatoid arthritis: a retrospective exploratory study.

Authors:  Pauline Fitzgerald; Heidi J Siddle; Michael R Backhouse; E Andrea Nelson
Journal:  J Foot Ankle Res       Date:  2015-08-16       Impact factor: 2.303

6.  Neuroprotective effect of erythropoietin against pressure ulcer in a mouse model of small fiber neuropathy.

Authors:  Aurore Danigo; Laurent Magy; Laurence Richard; Alexis Desmoulière; Sylvie Bourthoumieu; Benoît Funalot; Claire Demiot
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

7.  Reporting of Research Ethics in Studies Focusing on Foot Health in Patients with Rheumatoid Arthritis - A Systematic Review.

Authors:  Minna Stolt; Emilia Kielo-Viljamaa; Anne-Marie Laitinen; Riitta Suhonen; Helena Leino-Kilpi
Journal:  J Empir Res Hum Res Ethics       Date:  2021-10-14       Impact factor: 1.742

Review 8.  Recent Advances in Nano-Formulations for Skin Wound Repair Applications.

Authors:  Yue Lin; Zheyan Chen; Yinai Liu; Jiawen Wang; Wang Lv; Renyi Peng
Journal:  Drug Des Devel Ther       Date:  2022-08-16       Impact factor: 4.319

9.  Management of foot health in people with inflammatory arthritis: British Society for Rheumatology guideline scope.

Authors:  Lara S Chapman; Michael Backhouse; Lindsay Bearne; Lindsey Cherry; Gavin Cleary; Jasmine Davey; Rachel Ferguson; Adele Grieve; Philip Helliwell; Adam Lomax; Helen McKeeman; Alan Rawlings; Robin Rees; Robbie Rooney; Sarah Ryan; Lucy Sanders; Heidi J Siddle; Sue Varley; Louise Warburton; Jim Woodburn; Edward Roddy
Journal:  Rheumatology (Oxford)       Date:  2022-10-06       Impact factor: 7.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.